United Therapeutics Corp. (UTHR)
586.64
-4.56
(-0.77%)
USD |
NASDAQ |
Oct 28, 14:16
United Therapeutics Price : 586.64 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 587.10 | 593.00 | 582.66 | 591.20 | 457447.0 |
| Oct 26, 2026 | 589.11 | 593.50 | 584.50 | 592.84 | 577007.0 |
| Oct 23, 2026 | 584.92 | 590.98 | 576.24 | 587.50 | 637876.0 |
| Oct 22, 2026 | 568.69 | 590.79 | 562.86 | 584.79 | 895459.0 |
| Oct 21, 2026 | 553.63 | 566.55 | 550.06 | 563.49 | 455094.0 |
| Oct 20, 2026 | 547.14 | 564.97 | 545.58 | 553.88 | 443279.0 |
| Oct 19, 2026 | 539.10 | 560.00 | 534.61 | 543.15 | 498298.0 |
| Oct 16, 2026 | 545.49 | 551.76 | 530.18 | 533.12 | 668250.0 |
| Oct 15, 2026 | 545.24 | 551.82 | 538.07 | 541.51 | 545401.0 |
| Oct 14, 2026 | 543.18 | 546.89 | 523.95 | 540.03 | 883183.0 |
| Oct 13, 2026 | 551.59 | 553.99 | 542.23 | 543.40 | 538231.0 |
| Oct 12, 2026 | 553.49 | 555.58 | 547.76 | 550.10 | 840641.0 |
| Oct 09, 2026 | 528.92 | 551.15 | 528.92 | 549.16 | 577863.0 |
| Oct 08, 2026 | 545.00 | 545.00 | 524.79 | 532.78 | 1.435M |
| Oct 07, 2026 | 542.41 | 558.30 | 541.90 | 545.00 | 1.005M |
| Oct 06, 2026 | 537.19 | 546.16 | 527.33 | 541.62 | 1.213M |
| Oct 05, 2026 | 540.41 | 547.98 | 535.53 | 536.40 | 833723.0 |
| Oct 02, 2026 | 570.00 | 577.02 | 541.27 | 541.70 | 1.118M |
| Oct 01, 2026 | 557.53 | 585.79 | 556.76 | 571.38 | 1.691M |
| Sep 30, 2026 | 482.20 | 557.37 | 475.46 | 541.89 | 3.337M |
| Sep 29, 2026 | 485.54 | 487.62 | 471.34 | 481.47 | 439866.0 |
| Sep 28, 2026 | 473.84 | 486.98 | 470.76 | 485.54 | 628267.0 |
| Sep 25, 2026 | 474.04 | 479.97 | 470.40 | 475.45 | 472446.0 |
| Sep 24, 2026 | 472.72 | 481.32 | 468.97 | 472.21 | 585525.0 |
| Sep 23, 2026 | 498.82 | 500.05 | 487.73 | 489.42 | 433400.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 46.46 |
| MannKind Corp. | 3.40 |
| Gilead Sciences, Inc. | 159.56 |
| Insmed, Inc. | 96.84 |
| Alnylam Pharmaceuticals, Inc. | 228.83 |
Price Related Metrics
| PE Ratio | 20.98 |
| PS Ratio | 8.722 |
| PEG Ratio | 2.290 |
| Price to Book Value | 3.912 |
| Price to Free Cash Flow | 25.38 |
| Earnings Yield | 4.77% |
| Market Cap | 25.04B |
| PEGY Ratio | 2.290 |
| Operating PE Ratio | 19.60 |
| Normalized PE Ratio | 22.49 |